Search

Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2022

Advances in Ocular Oncology

Timothy G. Murray, MD, MBA

Show Description +

R.V. Paul Chan, MD, MSC, MBA, FACS, talks with the 2022 Taylor Smith & Victor Curtin Lecturer, Timothy G. Murray, MD, MBA, about his passion for ocular oncology and just how far the field has come in the past three decades. For one, therapy has moved away from enucleation and now focuses on globe-sparing approaches.

Posted: 4/05/2022

Keywords:

retina-meeting-recap

•

Ocular Oncology

•

enucleation

Up Next

Data Update: Faricimab for AMD & DME

Data Update: Faricimab for AMD & DME

Carl D. Regillo, MD

The Promise of Dry AMD Therapies

The Promise of Dry AMD Therapies

Joan W. Miller, MD

PDS Implantation Tips and Tricks

PDS Implantation Tips and Tricks

Carl C. Awh, MD, FASRS

Gene Therapy for IRDs: The How and Why of Imaging

Gene Therapy for IRDs: The How and Why of Imaging

Aleksandra Rachitskaya, MD; and Timothy G. Murray, MD, MBA

Advances in Diabetic Eye Disease Management

Advances in Diabetic Eye Disease Management

Judy E. Kim, MD; and Timothy G. Murray, MD, MBA

Clinical Insights from High-Resolution OCT

Clinical Insights from High-Resolution OCT

K. Bailey Freund, MD; Timothy Murray, MD

Complex RD? Consider Medium-Term PFO

Complex RD? Consider Medium-Term PFO

Steve Charles, MD, FACS, FICS

Three Decades of Surgical Training

Three Decades of Surgical Training

H. Culver Boldt, MD

Back to All Videos

Advances in Ocular Oncology

Timothy G. Murray, MD, MBA

R.V. Paul Chan, MD, MSC, MBA, FACS, talks with the 2022 Taylor Smith & Victor Curtin Lecturer, Timothy G. Murray, MD, MBA, about his passion for ocular oncology and just how far the field has come in the past three decades. For one, therapy has moved away from enucleation and now focuses on globe-sparing approaches.

Posted: 4/05/2022

Keywords:

retina-meeting-recap

•

Ocular Oncology

•

enucleation

Please log in to leave a comment.

More From ARDS: 2022 Coverage

Gene Therapy for IRDs: The How and Why of Imaging

Gene Therapy for IRDs: The How and Why of Imaging

Aleksandra Rachitskaya, MD; and Timothy G. Murray, MD, MBA

Advances in Diabetic Eye Disease Management

Advances in Diabetic Eye Disease Management

Judy E. Kim, MD; and Timothy G. Murray, MD, MBA

Clinical Insights from High-Resolution OCT

Clinical Insights from High-Resolution OCT

K. Bailey Freund, MD; Timothy Murray, MD

Complex RD? Consider Medium-Term PFO

Complex RD? Consider Medium-Term PFO

Steve Charles, MD, FACS, FICS

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARDS: 2022.